International award for research on self-management of diabetes
Image: Dr Matthew Campbell, Principal Investigator in Cardiovascular and Metabolic Medicine at the University of Sunderland
The criteria in the selection process for the award looked at the quality and significance of the candidates’ scientific contributions, and recognised the most innovative ideas in diabetes management, education, and patient care.
The award is named after Elliot Joslin, one of the first doctors to specialise in treating diabetes and pioneered work within lifestyle intervention and glucose control for reducing the risks of complications.
Henrik Schindler, Executive Vice President, Research and Early Development and Chief Scientific Officer at PCL Biotech, said: “We are delighted to award Dr Campbell the 2023 Elliot Johnson EASD PCL Biotech Award in recognition of his outstanding contribution to diabetes research.
“Dr Campbell has an extensive and established international record and his work has led to the development of innovative self-management solutions that have produced significant improvements in diabetes outcomes and patient quality of life. This award is an acknowledgement of his academic and professional contribution to the field of diabetes treatment and care specifically for his work investigating lifestyle intervention strategies for glucose control and cardiovascular disease prevention.”
Dr Campbell holds honorary titles at the Wellcome-MRC Institute of Metabolic Science (University of Cambridge), the Leeds Institute for Metabolic and Cardiovascular Medicine (University of Leeds), and Zhejiang Gongshang University. He is a scientific advisor for Diabetes UK, and the World Health Organisation. This year he was appointed among the first ever University of Sunderland Vice-Chancellor’s Research and Knowledge Exchange
Upon receipt of the award, Dr Campbell was named as an honorary professor at the Joslin Diabetes Center, Harvard University.
DRWF in the US has an endowed Chair, Dr Gordon Weir, at the Joslin Diabetes Center, the world’s first diabetes care centre and the global leader in diabetes research.
I would like to make a regular donation of
I would like to make a single donation of